Mission Viejo, CA, United States of America

Yong-Xin Li

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yong-Xin Li: Innovator in Pharmaceutical Compositions

Introduction

Yong-Xin Li is a notable inventor based in Mission Viejo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various disorders. With a total of 3 patents to his name, his work has the potential to impact many lives.

Latest Patents

Li's latest patents include innovative pharmaceutical compositions that utilize D-serine transporter inhibitors. One of his inventions focuses on the treatment of visual system disorders, providing therapeutic methods that enhance visual function. Another patent addresses central nervous system disorders, showcasing the versatility and importance of D-serine transporter inhibitors in medical applications.

Career Highlights

Yong-Xin Li is currently associated with Allergan, Inc., a company known for its commitment to developing innovative healthcare solutions. His work at Allergan has allowed him to explore and expand the potential of pharmaceutical compositions, contributing to advancements in treatment methodologies.

Collaborations

Throughout his career, Li has collaborated with esteemed colleagues such as Alan C Foster and Ursula V Staubli. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.

Conclusion

Yong-Xin Li's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for new treatments that can significantly benefit patients with visual and central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…